Humana vs Medline

Humana (HUM), health care, and Medline (MDLN), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Humana is worth $52.9B on the stock market and Medline $50.2B: Humana is valued at 6% more. Humana trades at 43.0 times earnings and Medline at 86.6; operating margins in their latest fiscal years were 2.09% and 7.78%. Over the past year Humana's share price has moved +97.0% and Medline's -4.46%.

Key facts

Humana market value
$52.9B
Medline market value
$50.2B
Humana P/E
43.0
Medline P/E
86.6
Humana revenue
$129.7BFY to 2025-12-31
Medline revenue
$28.4BFY to 2025-12-31
Superinvestors holding both
1

Market values as of .

Humana vs Medline: every measure side by side
Measure Humana Medline
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2025-12-312025-12-31
Size
Market cap$52.9Bhigher$50.2Blower
Revenue$129.7Bhigher$28.4Blower
Earnings$1.2Bhigher$1.2Blower
Employees67,060higher45,000lower
Total assets$48.9Bhigher$38.5Blower
Valuation
P/E43.0lower86.6higher
P/S0.4lower1.8higher
P/B2.8lower2.8higher
Dividend yield0.77%higher0.00%lower
Profitability
Operating margin2.09%lower7.78%higher
Balance sheet
Net assets$17.7Bhigher$10.7Blower
Total liabilities$31.2Bhigher$19.2Blower
Total debt$12.4Blower$12.6Bhigher
Cash on hand$4.2Bhigher$1.9Blower
Price change
Today-4.47%lower-2.71%higher
1 year+97.0%higher-4.46%lower

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Percentages are each holding's share of that investor's reported portfolio (under "Both": Humana / Medline). Who owns HUM · Who owns MDLN

Further comparisons

Learn

Questions and answers

Which is bigger, Humana or Medline?

By market value, Humana is the larger: $52.9B against $50.2B for Medline. By revenue in its latest fiscal year, Humana is the larger: $129.7B against $28.4B for Medline.

Which has the higher P/E ratio?

Medline: 86.6, against 43.0 for Humana. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

Which has the higher operating margin?

Medline: 7.78%, against 2.09% for Humana. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which has the higher dividend yield?

Humana: 0.77%, against 0.00% for Medline. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which has more debt?

Medline: $12.6B, against $12.4B for Humana. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

Which superinvestors own both Humana and Medline?

In their latest 13F filings, George Soros holds both.

Cite this page

Funkfolio, “Humana vs Medline”, data as of 17 November 2026. https://funkfolio.com/compare/hum-vs-mdln

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.